Description
The VA National Acquisition Center is seeking a commercial supplier to provide Glipizide tablets (5 mg and 10 mg) in unit‑of‑use bottles of various pack sizes for distribution through VA and DoD pharmaceutical prime‑vendor programs. The contract will be a firm‑fixed‑price, indefinite‑delivery/requirements arrangement with a one‑year base period and up to four one‑year options (maximum five‑year term). Offerors must supply products under a unique label (unique NDC) and meet detailed packaging, safety‑cap, label‑size, and barcode requirements. All bids must be received by the extended deadline of October 8, 2026 14:30 CT.
• Supply Glipizide tablets in 90, 180, 360, 500, and 1 000 tablet bottles, meeting strict labeling, safety‑cap, and barcode specifications.
• Provide a unique 11‑digit NDC for each product; the label will be the sole label on the product, with VA adding its own label over it.
• Contract is unrestricted (open to any responsible source), with a base‑year quantity of approximately 332,862 bottles and identical quantities for each optional year.